Pulmonary hypertension in patients with chronic myeloproliferative disorders

Adir Yochai, Elia Davide, Harari Sergio

Source: Eur Respir Rev 2015; 24: 400-410
Journal Issue: September
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Adir Yochai, Elia Davide, Harari Sergio. Pulmonary hypertension in patients with chronic myeloproliferative disorders. Eur Respir Rev 2015; 24: 400-410

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension in patients with chronic myeloproliferative disorders
Source: Eur Respir J 2010; 35: 1396-1406
Year: 2010



Prevalance of pulmonary hypertension in chronic myeloproliferative diseases
Source: Annual Congress 2011 - Novel clinical features of acute and chronic lung diseases
Year: 2011


Pulmonary veno-occlusive disease in myeloproliferative disorder
Source: Eur Respir J 2009; 33: 213-216
Year: 2009



Pulmonary hypertension associated with myeloproliferative disorders suggesting pulmonary veno-occlusive disease: a retrospective study of six cases
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009


Prospective evaluation of pulmonary vascular involvement in patients with chronic myeloproliferative disorders
Source: Annual Congress 2007 - Pulmonary hypertension
Year: 2007


Pulmonary disorders in chronic renal failure
Source: Eur Respir J 2005; 26: Suppl. 49, 545s
Year: 2005

A study of hematologic disorders in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Sleep disorders in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Year: 2020


Osteoporosis in patients with idiopathic and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007


Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a psychiatric disorder
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018


Prediction of vascular-platelet hemostasis disorders in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020


Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011

Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005

Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006

Pulmonary manifestations in adult patients with chronic granulomatous disease
Source: Eur Respir J 2015; 45: 1613-1623
Year: 2015



The pulmonary disorders associated with autoimmune pancreatitis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Cardiovascular comorbidities in chronic obstructive pulmonary disease patients
Source: International Congress 2017 – COPD biomarkers
Year: 2017